1. U.S. Pharmacogenomics Markets Key Alliances and Pro-Active Networking Efforts Essential for Success "Investors and established companies should begin scouting start-up companies and academic laboratories for innovative technologies." Drug Discovery and Biotechnology Analyst Team Frost & Sullivan

2. Detailed insights into recent developments and trends Drivers, restraints, challenges, and strategic recommendations Analytical insights into current topics and emerging applications in the pharmacogenomics market Market-sizing and competitive analysis Market forecasts and opportunity analyses Quarterly assessments End-user analysis Key Features

3. Coverage: The United States Proven methodology using extensive primary and secondary data as well as research Focused information and strategies that cover business and technology issues Credible data and analyses that highlight industry dynamics Precise strategies to help you create winning business plans What We Offer

4. Current Market Participants Find out where you stand in comparison with the competitors Assess current and future drivers as well as restraints Determine and exploit new market share opportunities New Entrants Analyze the associated challenges Calculate timescales for strategy implementation Position yourself to capitalize on the unmet needs of the market Investment Community Analyze long-term strategies of companies Determine which participants will outperform the competition Assess the attractiveness of investing in the market Benefits

5. Acadia Pharmaceuticals Affymetrix, Inc. Amgen AP Biotech Applera Corp. Arius Research ArQule AstraZeneca Aventis (USA) Base4, Inc. Bayer (USA) BioMérieux BioTechnology General Corp. Boehringer Ingelheim (USA) Bristol-Myers Squibb Co. Clontech Laboratories, Inc. CuraGen Corp. Key Market Participants Élan (USA) Eli Lilly and Co. EM Industries (USA) ExonHit Therapeutics Ferring Pharmaceuticals, Inc. (USA) Genaissance Pharmaceuticals, Inc. Genentech, Inc. Genta GlaxoSmithKline Hoffmann-La Roche Hybrigenics Incyte Pharmaceuticals InterMune Pharmaceuticals Invitrogen Corp. Lorus Therapeutics, Inc. Matrix Pharmaceuticals, Inc. MDS Ocata, Inc.

6. Medicis Merck Microarray Centre Molecular Templates Nabi Nova Biomedical Novartis (USA) OmniViz, Inc. Ontario Cancer Institute Orchid BioSciences, Inc. Orphan Australia Pty Ltd. Orphan Europe SARL Orphan Medical, Inc. Orphan Pharmaceuticals Orphan Pharma International Packard Instrument Co. Key Market Participants (cont’d) Pierre Fabre SA Pfizer Pharmaceuticals Group PPGx, Inc. Qiagen Genomics Sanofi-Syntélabo (USA) Sequenom, Inc. Shire Pharmaceuticals Group (USA) Sigma-Tau Pharmaceuticals, Inc. (USA) SignalGene, Inc. Swedish Orphan Teva Pharmaceuticals (USA) Therapeutic Goods Administration Third Wave Technologies TM BioScience Corp. Visible Genetics, Inc. YM Biosciences, Inc.

7. Call toll free 877 G O F ROST (877.463.7876) Fax toll free 888.690.3329 E-mail myfrost@frost.com Visit www.frost.com For More Information